Does Adding Bevacizumab Therapy in Glaucoma Surgery Improve the Success of Needle Bleb Revisions?
| Status: | Completed |
|---|---|
| Conditions: | Ocular |
| Therapuetic Areas: | Ophthalmology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 7/11/2018 |
| Start Date: | February 2009 |
| End Date: | January 2012 |
Does a New Add on (or Adjunctive) Therapy Used in Glaucoma Surgery Improve the Success of Needle Bleb Revisions?
The purpose of this study is to see if a new add on (or adjunctive) therapy used in glaucoma
surgery improves the success of needle bleb revisions.
surgery improves the success of needle bleb revisions.
To investigate the efficacy of needle bleb revisions with mitomycin C with subconjunctival
bevacizumab in promoting both filtering success and favorable bleb morphologic features.
bevacizumab in promoting both filtering success and favorable bleb morphologic features.
Inclusion Criteria:
- require glaucoma bleb needle revision with Mitomycin-C
Exclusion Criteria:
- pregnant, nursing, or not using adequate contraception
- other glaucoma eye surgery involving tube shunts
- prior retinal detachments surgery with scleral buckle
- infection, inflammation, or any abnormality preventing eye pressure measurement
- enrolled in another investigational study
We found this trial at
1
site
Click here to add this to my saved trials
